Delivery Order 75N93018D00001-75N93021F00003
Award Date
4/2/21
Potential Completion Date
2/28/22
Potential Value
$143K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Sri International
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
West Menlo Park, CA 94025, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS). The $6,179,640.00 cost-plus-fixed-fee contract was awarded to Sri International, a non-profit research and development institute, to provide non-clinical studies in support of Investigational New Drug (IND), New Drug Application (NDA), and Biologics License Application (BLA) submissions. The work will take...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1.3 million delivery order contract to Sri International of West Menlo Park, California under the master indefinite-delivery indefinite-quantity contract titled Nonclinical Services for Development of Interventional Agents. The 24-month cost-plus-fixed-fee contract provides nonclinical services for the development of interventional agents for infectious diseases to support the Department of...
This is a federal contract award to Sri International, a non-profit research and development institute, by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS). The contract, a Delivery Order with a cost plus fixed fee pricing type, is for pre-clinical services to support the development of interventional agents for infectious diseases. The contract has a ceiling value of $5,491,527.88 and a period of...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $115,733 firm-fixed-price delivery order contract to Sri International, a non-profit research institute, for nonclinical services to support the development of interventional agents for infectious diseases. The contract has an estimated completion date of April 30, 2024 and is not set aside for any specific business type. Sri International has extensive...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $451,555 delivery order contract to Sri International under the master indefinite-delivery indefinite-quantity contract titled "Nonclinical Services for Development of Interventional Agents." The contract is for Sri International to provide nonclinical services for the development of interventional agents for infectious diseases from September 1,...
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Sri International, a non-profit research institute. The $260,406.00 contract is for task order B-01 under the "Nonclinical Services for Development of Interventional Agents" indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The task order is for lead identification, development,...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded Sri International a $10.9 million delivery order against the Nonclinical Services for Development of Interventional Agents indefinite-delivery/indefinite-quantity contract. Under this award, Sri International will provide nonclinical microbiological, safety, toxicology, and pharmacokinetic services in support of the development of interventional agents to address infectious diseases. Work will be...
Sri International has been awarded a $8.96 million delivery order against the Nonclinical Services for Development of Interventional Agents master IDIQ contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The delivery order is for nonclinical services to support the development of interventional agents for infectious diseases. Work will be performed by Sri International in West Menlo Park, California over a one year period concluding in March...
This is a cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Sri International, a non-profit research and development institute. The $25,378,188.00 contract is for safety evaluations of anti-infective therapies, with a period of performance ending on July 30, 2007. Sri International, which has expertise across various scientific and engineering...
This is a $4,950,919.00 federal contract award to SRI International, a non-profit research and development institute, to provide nonclinical services for the development of interventional agents for infectious diseases. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. SRI International has a robust history of providing advanced scientific and technical services to the federal...